Van Horssen et al.; Identification of the Region within the Neuroendocrine Polypeptide 7B2 Responsible for the Inhibition of Prohormone Convertase PC2, 1995, Journal of Biological Chemistry, vol. 270: 14292-14296.* |
Sigmund; Viewpoint: Are Studies in Genetically Altered Mice Out of Control?, 2000, Arterioscler Thromb Vasc. biol. 20: 1425-1429.* |
Bradley et.al.; Modifying the Mouse: Design and Desire, 1992, Bio/Technology, vol. 10: 534-539.* |
Kappel et.al.; Regulating gene expression in transgenic animals, 1992, Current Opinion in Biotechnology 3: 548-553.* |
Melton; Gene Targeting in the Mouse, 1994, BioEssays, vol. 16, No. 9: 633-638.* |
Moreadith et.al.; Gene targeting in embryonic stem cells: the new physiology and metabolism, 1996, J Mol Med 75: 208-216.* |
Rudinger; Characteristics of the amino acids as components of a peptide hormone sequence.* |
Ngo et.al.; computational Complexity, Protein Structure Prediction, and the Levinthal Paradox, 1994, Protein Folding Problem and Tertiary Structure Prediction: 491-494.* |
Seamark. Reprod. Fertil. Dev. 6: 653-657, see entire documen, especially p. 654, column 2, paragraph 3; and abstract, 1994.* |
Mullins et al. (Journal of Clinical Investigation 98(11): S37-S40 See especially S39, 1996.* |
Wall. Theriogenology, 45: 57-68 See especially p. 61, last paragraph and p. 62, first paragraph, 1996.* |
Martens (FEBS Lett. 234(1): 160-164, See abstract and p. 160, paragraph bridging columns 1 and 2, Jul. 1988.* |
Mbikay, GenBank Accession No. X15830, Mar. 1994.* |
Capecchi (Trends in Genetics 5(3): 70-76, See p. 75, first sentence of first full paragraph, Mar. 1989.* |
Zhu et al (J. Cell. Biol. 129(6):1641-1650,See abstract, p. 1645, column 2, first full paragraph; and Fig. 6, p. 1646, especially panel C, Jun. 1995.* |
Gherzi et al (Exp. Cell Res. 213(1): 20-27, see abstract. and pava. bridging columas 162 on p. 23, Jul. 1994.* |
Braks et al., “Dissociation of the Complex Between the Neuroendocrine Chaperone 7B2 and Prohormone Convertase PC2 is Not Associated With proPc2 Maturation,” Eur. J. Bichem. 238: 505-510, 1996. |
Braks et al., “Structural Organization of the Gene Encoding the Neuroendocrine Chaperone 7B2,” Eur. J. Biochem 236: 60-67, 1996. |
Braks and Martens, “The neuroendocrine chaperone 7B2 can enhance in vitro PoMC cleavage by prohormone convertase PC2,” FEBS Lett. 371: 154-158, 1995. |
Braks and Martens, “7B2 is a Neuroendocrine Chaperone that Transiently with Prohormone Convertase PC2 in the Secretory Pathway,” Cell 78:263-273, 1994. |
Capecchi M.R., “The New Mouse Genetics: Altering the Genome by Gene Targeting,” Trends Genet. 5: 70-76, 1989. |
Corral et al., “An MII-AF9 fusion gene made by homologous recombination causes acute leukemia in chimeric mice: A method to create fusion oncogenes,” Cell 85: 853-861, 1996. |
Devine et al., “A transposon-based strategy for sequencing repetitive DNA in eukaryotic genomes,” Genome Research 7: 551-563, 1997. |
Devine and Boeke, “Efficient intergration of artificial transposon to plasmid targets in vitro: a useful tool for DNA mapping, sequencing and genetic analysis,” Nucelic Acids Research 22: 3765-3772, 1994. |
Hoekstra, M.F., “Responses to DNA damage and regulation of cell cycle checkpoints by the ATM protein kinase family,” Current Opinion in Genetics & Development 7: 170-175, 1997. |
Deng et al., “Mice Lacking p21 (CIP1/WAP1) Undergo Normal Development, But Are Defective in G1 Checkpoint Control,” Cell 82: 675-684, 1995. |
Lindberg et al., “Enymatic Characterization of Immunopurified Prohormone Convertase 2: Potent Inhibition by a 7B2 Peptide Fragment,” Biochemistry 34: 5486-5493, 1995. |
Martens, G.J.M., “Cloning and Sequence Analysis of Human Pituitary cDNA Encoding the Novel Polypeptide 7B2,” FEBS Lett. 234: 160-164, 1988. |
McCormick et al., “Expression of human apolipoprotein B90 in transgenic mice,” Journal of Biological Chemistry 269: 24284-24289, 1994. |
Meiner et al., “Disruption of the acyl-CoA: Cholesterol Acytransferase Gene in Mice: Evidence Suggesting Multiple Cholesterol Esterification Enzymes in Mammals,” Proc. Natl. Acad. Sci. USA 93: 14041-14046, 1996. |
Morgan et al., “Transposon tools for recombinant DNA manipulation: Characterization of transcriptional regulators from yeast, Xenopus, and mouse,” Proc. Natl. Acad. Sci. USA 93: 2801-2806, 1996. |
Seidah and Chretien, “Proprotein and Prohormone Convertases of the Subtilisin Family,” Trends Endocrinol. Metabol. 3: 133-140, 1992. |
Steiner et al., “The New Enymology of Precurson Processing Endoproteases,” J. Biol. Chem. 267: 23435-23438, 1992. |
Tybulewicz et al., “Neonatal Lethality and Lymphopenia in Mice with a Homozygous Disruption of the c-abl Proto-Oncogene,” Cell 85: 1153-1163, 1991. |
Waldbieser et al., “Cloning and characterization of the rat complementary deoxyribonucleic acid and gene encoding the neuroendocrine peptide 7B2,” Endocrinology 128: 3228-3236, 1991. |
Wang et al., “The Mouse formin (Fmn) Gene: Genomic Structure, Novel Exons, and Genetic Mapping,” Genomics 39: 303-311, 1997. |
Westpal and Leder, “Transposon-generated ‘knock out’ and knock in gene-targeting constructs for use in mice,” Current Biology 7: 530-533, 1997. |
Westphal et al., “Genetic interactions between atm and p53 influence cellular proliferation and irradiation-induced cell cycle checkpoints,” Cancer Research 57: 1664-1667, 1997. |
Westphal et al., “atm and p53 cooperate in apoptosis and suppression of tumorigenesis, but not in resistance to acute radiation toxicity,” Nature Genetics 16: 397-401, 1997. |
Westphal et al., The neuroendocrine protein 7B2 is required for peptide hormone processing in vivo and provides a novel mechanism for pituitary Cushing's disease. Cell 96: 689-700, 1999. |
Zhu et al., “Involvement of a Polyproline Helix-Like Structure in the Interactin of 7B2 with Prohormone Convertase 2,” J. Biol. Chem. 271: 23582-23587, 1996. |
Zhu et al., “Internal Cleavage of the Inhibitory 7B2 Carboxyl-Terminal Peptide by PC2: A Potential Mechanism for its Inactivation,” Proc. Natl. Acad. Sci. USA 93: 4919-4924, 1996. |
Zhu and Lindberg, “7B2 Facililtates the Maturation of proPC2 in Neuroendocrine Cells and is Required for the Expression of Ezymatic Activity,” J. Cell. Biol. 129: 1641-1650, 1995. |